| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADAM-17: a novel therapeutic target for triple negative breast cancer
|
|
|
|
24 |
8 |
p. 2199
|
artikel
|
| 2 |
A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
|
Simons, C.C.J.M.
|
|
|
24 |
8 |
p. 2048-2056
|
artikel
|
| 3 |
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer
|
Powles, T.
|
|
|
24 |
8 |
p. 2098-2103
|
artikel
|
| 4 |
Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care
|
Brédart, A.
|
|
|
24 |
8 |
p. 2151-2158
|
artikel
|
| 5 |
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients
|
Cetina, L.
|
|
|
24 |
8 |
p. 2043-2047
|
artikel
|
| 6 |
Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observation
|
Baselga, Jose
|
|
|
24 |
8 |
p. 1956-1957
|
artikel
|
| 7 |
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network †
|
Cheah, C.Y.
|
|
|
24 |
8 |
p. 2119-2123
|
artikel
|
| 8 |
Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer
|
Bodelon, C.
|
|
|
24 |
8 |
p. 2073-2079
|
artikel
|
| 9 |
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
|
Bidard, F.C.
|
|
|
24 |
8 |
p. 2057-2061
|
artikel
|
| 10 |
Concern on quality-of-life analysis in the OPTIMAL study
|
Couraud, S.
|
|
|
24 |
8 |
p. 2196-2197
|
artikel
|
| 11 |
Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)
|
Fedirko, V.
|
|
|
24 |
8 |
p. 2166-2173
|
artikel
|
| 12 |
Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer
|
Bai, J.
|
|
|
24 |
8 |
p. 2016-2022
|
artikel
|
| 13 |
Current status of screening for colorectal cancer
|
Garborg, K.
|
|
|
24 |
8 |
p. 1963-1972
|
artikel
|
| 14 |
Editorial board
|
|
|
|
24 |
8 |
p. ii-iii
|
artikel
|
| 15 |
Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma
|
Maraldo, M.V.
|
|
|
24 |
8 |
p. 2113-2118
|
artikel
|
| 16 |
European Consensus Conference for external quality assessment in molecular pathology
|
van Krieken, J.H.
|
|
|
24 |
8 |
p. 1958-1963
|
artikel
|
| 17 |
Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)
|
Yan, Y.
|
|
|
24 |
8 |
p. 1986-1993
|
artikel
|
| 18 |
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial
|
Criscitiello, C.
|
|
|
24 |
8 |
p. 1980-1985
|
artikel
|
| 19 |
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)
|
Fornaro, L.
|
|
|
24 |
8 |
p. 2062-2067
|
artikel
|
| 20 |
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
|
Wolchok, J.D.
|
|
|
24 |
8 |
p. 2174-2180
|
artikel
|
| 21 |
Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution
|
Mattavelli, D.
|
|
|
24 |
8 |
p. 2181-2189
|
artikel
|
| 22 |
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
|
Lorenzen, S.
|
|
|
24 |
8 |
p. 2068-2073
|
artikel
|
| 23 |
Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors
|
Choueiri, T.K.
|
|
|
24 |
8 |
p. 2092-2097
|
artikel
|
| 24 |
Is intraductal papillary mucinous neoplasm associated with extrapancreatic malignancies? Which is the true, prevalence or incidence?
|
Kawakubo, K.
|
|
|
24 |
8 |
p. 2196
|
artikel
|
| 25 |
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
|
Wu, X.
|
|
|
24 |
8 |
p. 2131-2136
|
artikel
|
| 26 |
Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes
|
Henary, H.
|
|
|
24 |
8 |
p. 2158-2165
|
artikel
|
| 27 |
Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype
|
Rampias, T.
|
|
|
24 |
8 |
p. 2124-2131
|
artikel
|
| 28 |
Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma
|
Horwich, A.
|
|
|
24 |
8 |
p. 2104-2107
|
artikel
|
| 29 |
Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer
|
Weiner, M.
|
|
|
24 |
8 |
p. 1994-1999
|
artikel
|
| 30 |
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
|
Crown, J.
|
|
|
24 |
8 |
p. 2005-2011
|
artikel
|
| 31 |
Osteosarcoma of the mobile spine †
|
Zils, K.
|
|
|
24 |
8 |
p. 2190-2195
|
artikel
|
| 32 |
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
|
Vencken, P.M.L.H.
|
|
|
24 |
8 |
p. 2036-2042
|
artikel
|
| 33 |
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
|
Kim, M.M.
|
|
|
24 |
8 |
p. 1999-2004
|
artikel
|
| 34 |
Personalised cancer management: closer, but not here yet
|
Piccart, M.
|
|
|
24 |
8 |
p. 1951-1955
|
artikel
|
| 35 |
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer †
|
Sun, J.-M.
|
|
|
24 |
8 |
p. 2088-2092
|
artikel
|
| 36 |
Predictors of recovery of ovarian function during aromatase inhibitor therapy
|
Henry, N.L.
|
|
|
24 |
8 |
p. 2011-2016
|
artikel
|
| 37 |
Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study
|
Lee, J.K.
|
|
|
24 |
8 |
p. 2080-2087
|
artikel
|
| 38 |
Reply to ‘Concern on quality-of-life analysis in the OPTIMAL study’ by Couraud et al
|
Zhou, C.
|
|
|
24 |
8 |
p. 2197-2198
|
artikel
|
| 39 |
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
|
Rahma, O.E.
|
|
|
24 |
8 |
p. 1972-1979
|
artikel
|
| 40 |
Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials
|
OuYang, P.Y.
|
|
|
24 |
8 |
p. 2136-2146
|
artikel
|
| 41 |
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis
|
Heemskerk-Gerritsen, B.A.M.
|
|
|
24 |
8 |
p. 2029-2035
|
artikel
|
| 42 |
Table of Contents
|
|
|
|
24 |
8 |
p. iv-vi
|
artikel
|
| 43 |
The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I–II and the sentinel node area
|
Belkacemi, Y.
|
|
|
24 |
8 |
p. 2023-2028
|
artikel
|
| 44 |
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
|
Luminari, S.
|
|
|
24 |
8 |
p. 2108-2112
|
artikel
|
| 45 |
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation
|
Ribeiro, C.
|
|
|
24 |
8 |
p. 2147-2150
|
artikel
|
Tijdschrift beschrijving